BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36473918)

  • 41. [Predictive performance of Smart Dose, PharmVan and JPKD on Vancomycin plasma concentration].
    Han L; Xu F; Zhang X; Wang Y; Lin G; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):263-268. PubMed ID: 33834965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Risk factors for death in elderly patients admitted to intensive care unit after elective abdominal surgery: a consecutive 5-year retrospective study].
    Li S; He T; Shen F; Wang D; Liu X; Qin J; Xiao C; Li W; Li Q; Gao D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Dec; 33(12):1453-1458. PubMed ID: 35131012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
    Boonyawan K; Gomez DR; Komaki R; Xu Y; Nantavithya C; Allen PK; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):919-926. PubMed ID: 29976504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.
    Teguh DN; Levendag PC; Ghidey W; van Montfort K; Kwa SL
    Dysphagia; 2013 Sep; 28(3):388-94. PubMed ID: 23355106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer: An observational study.
    Zhao T; Jin Y; Mao G; Wei Y; Wu G; Ye X; Zhou Y; Yuan G; Gao L; Hong Y; Chen Y; Hong C; Zhou H; Su D; Qin Z; Lu L
    Medicine (Baltimore); 2016 Dec; 95(52):e5748. PubMed ID: 28033287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influencing factors and their predictive value of skin graft survival after Meek grafting in severe burn patients].
    Zhang P; Yuan LL; Luo J; Song HP; Xiang F; Luo GX; Huang YS
    Zhonghua Shao Shang Za Zhi; 2021 Mar; 37(3):243-249. PubMed ID: 33618447
    [No Abstract]   [Full Text] [Related]  

  • 48. XGBoost algorithm and logistic regression to predict the postoperative 5-year outcome in patients with glioma.
    Yan Z; Wang J; Dong Q; Zhu L; Lin W; Jiang X
    Ann Transl Med; 2022 Aug; 10(16):860. PubMed ID: 36110992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model.
    Dranitsaris G; Clemons M; Verma S; Lau C; Vincent M
    Lancet Oncol; 2005 Nov; 6(11):856-63. PubMed ID: 16257793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-radiotherapy systemic immune inflammation index associated with overall survival in patients with advanced EGFR mutant non-small cell lung cancer receiving thoracic radiotherapy.
    Chen D; Qin H; Deng G; Wang Q; Wang H; Liu X
    Clin Transl Oncol; 2023 Jan; 25(1):226-235. PubMed ID: 36070068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Exploration of the rational therapeutic regimen for advanced lung cancer patients with mild tumor enlargement].
    Zhang XL; Wang XY; Zhang CC; Yang J; Yuan XH; Li K
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):775-782. PubMed ID: 29061023
    [No Abstract]   [Full Text] [Related]  

  • 52. [Analysis of prognosis risk factors of critically ill patients after cardiac surgery: a consecutive 5-year retrospective study].
    Gong C; Liu X; Tang Y; Huang Y; Fang H; Cheng Y; Liu Y; Wang D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):873-877. PubMed ID: 31441413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: implication for treatment strategies.
    Sha S; Dong J; Wang M; Chen Z; Gao P
    World J Surg Oncol; 2021 Jul; 19(1):214. PubMed ID: 34271911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
    Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
    [No Abstract]   [Full Text] [Related]  

  • 55. A combined predictive model based on radiomics features and clinical factors for disease progression in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Yang H; Wang L; Shao G; Dong B; Wang F; Wei Y; Li P; Chen H; Chen W; Zheng Y; He Y; Zhao Y; Du X; Sun X; Wang Z; Wang Y; Zhou X; Lai X; Feng W; Shen L; Qiu G; Ji Y; Chen J; Jiang Y; Liu J; Zeng J; Wang C; Zhao Q; Yang X; Hu X; Ma H; Chen Q; Chen M; Jiang H; Xu Y
    Front Oncol; 2022; 12():967360. PubMed ID: 35982975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incorporation of PET Metabolic Parameters With Clinical Features Into a Predictive Model for Radiotherapy-Related Esophageal Fistula in Esophageal Squamous Cell Carcinoma.
    Li K; Ni X; Lin D; Li J
    Front Oncol; 2022; 12():812707. PubMed ID: 35296024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
    De Ruysscher D; Dehing C; Bremer RH; Bentzen SM; Koppe F; Pijls-Johannesma M; Harzée L; Minken A; Wanders R; Hochstenbag M; Dingemans AM; Boersma L; van Haren E; Geraedts W; Pitz C; Simons J; Wouters B; Rosier JF; Lambin P
    Ann Oncol; 2007 May; 18(5):909-16. PubMed ID: 17322546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Establishment of A Clinical Prediction Model of Solid Solitary Pulmonary Nodules].
    Yu W; Ye B; Xu L; Wang Z; Le H; Wang S; Cao H; Chai Z; Chen Z; Luo Q; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):705-710. PubMed ID: 27760603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
    Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.